levodopa has been researched along with Nervous System Disorders in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (42.55) | 18.7374 |
1990's | 15 (31.91) | 18.2507 |
2000's | 3 (6.38) | 29.6817 |
2010's | 9 (19.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bishop, C | 1 |
Beck, JP; Bruns, RF; Carter, G; Chernet, E; Eastwood, BJ; Falcone, JF; Hao, J; Harper, AJ; Katner, JS; Li, X; Love, PL; Maren, DL; Masquelin, ME; Menezes, MM; Mitchell, SN; Murray, TK; O'Neill, MJ; Ryder, JW; Schaus, JM; Shanks, EA; Svensson, KA; Thompson, LK; Wafford, KA; Wang, H; Witkin, JM; Yang, CR; Zhang, L | 1 |
Martey, J; Rajabally, YA | 1 |
Schneemilch, C | 1 |
Allen, GF; Clayton, PT; Footitt, EJ; Heales, SJ; Mills, PB; Oppenheim, M | 1 |
Chao, OY; Huston, JP; Li, JS; Pum, ME | 1 |
Krzyściak, W | 1 |
Blau, N; Dill, P; Somerville, A; Thöny, B; Wagner, M; Weber, P | 1 |
Barker, RA; Brooks, DJ; Burn, DJ; Coleman, S; Duncan, GW; Khoo, TK; O'Brien, JT; Yarnall, AJ | 1 |
Mrowka, M; Odin, P; Shing, M | 1 |
Ikemoto, K | 1 |
Aubin, N; Barneoud, P; Burnier, P; Caille, D; Carter, C; Charieras, T; Curet, O; Gardes, A; George, P; Jegham, S; Le Kim, A; Lolivier, J; Marc, C; Pandini, M; Perron, C; Puech, F; Scatton, B; Sontag, N | 1 |
Iadgarov, IS | 1 |
Yung, CY | 1 |
Gerber, JC; Grossman, MH; Hare, TA; Katz, L; Manyam, NV | 1 |
Caraceni, T; Cocchi, D; Giovannini, P; Martinez-Campos, A; Müller, EE; Parati, EA; Zanardi, P | 1 |
Sacks, OW | 1 |
Markova, ED; Shmidt, EV; Tkachev, RA | 2 |
Calne, DB; Chu, NS; Huang, CC; Lu, CS | 1 |
Aronowitz, JS; Gordon, MF; Kane, JM; Lieberman, JA; Pollack, S; Safferman, AZ | 1 |
Fiszer, U; Fredrikson, S; Kostulas, V; Link, H; Mix, E; Olsson, T | 1 |
Calne, DB; Chu, NS; Hochberg, F; Huang, CC; Lilienfeld, D; Lu, CS; Olanow, W | 1 |
Blankson, S; Daniel, SE; Hughes, AJ; Lees, AJ | 1 |
Dickson, DW; Duvoisin, RC; Mark, MH; Sage, JI | 1 |
Benhadjali, J; Bughin, M; Delalande, I; Destée, A; Forzy, G; Hache, JC | 1 |
Albanese, A; Colosimo, C; Lees, AJ; Tonali, P | 1 |
Brefel-Courbon, C; Fabre, N; Rascol, O | 1 |
Aitken, JW; Fotteler, B; Jorga, KM; Nielsen, T; Sedek, G; Zürcher, G | 1 |
Simuni, T; Stern, MB | 1 |
Greer, M | 1 |
Seyfert, S; Straschill, M | 1 |
Bannister, R | 1 |
Moskowitz, MA; Wurtman, RJ | 1 |
Gerstenbrand, F; Gründig, E; Weiss, J | 1 |
Zenkov, LR | 1 |
Abroms, IF; Breslow, JL; Brewster, TG; Kaufman, S; Milstien, S; Moskowitz, MA | 1 |
Binswanger, U; Keusch, G; Oswald, N | 1 |
De Lean, J; Deck, JH | 1 |
Kuran, W | 1 |
Wagner, GC; Walsh, SL | 1 |
Klein, AT; Langford, HG; Montani, M; Subramony, SH | 1 |
Black, CK; Schmidt, CJ; Taylor, VL | 1 |
Dickey, W; Morrow, JI | 1 |
Lungol, VN; Mikhaĭlenko, ET; Veropotvelian, PN; Zavgorodniaia, LI | 1 |
Breck, L; Cedarbaum, JM; Kutt, H; McDowell, FH | 1 |
Blonder, J; Cohen, BE; Normand, M; Peled, I; Quint, J; Szeinberg, A | 1 |
10 review(s) available for levodopa and Nervous System Disorders
Article | Year |
---|---|
Activity of selected aromatic amino acids in biological systems.
Topics: Biomarkers; Cardiovascular Diseases; Enzyme Activation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Levodopa; Melanins; Monophenol Monooxygenase; Nervous System Diseases; Oxidative Stress; Renal Insufficiency, Chronic; Serotonin; Tryptophan; Tyrosine | 2011 |
Restless legs syndrome.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Child; Diagnosis, Differential; Dopamine Agonists; Humans; Levodopa; Narcotics; Nervous System Diseases; Neurologic Examination; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders | 2002 |
Significance of human striatal D-neurons: implications in neuropsychiatric functions.
Topics: Animals; Antiparkinson Agents; Dopa Decarboxylase; Humans; Levodopa; Limbic System; Mental Disorders; Neostriatum; Nervous System Diseases; Neurons | 2004 |
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
Growth hormone secretion in neurological disorders.
Topics: Benserazide; Disease Models, Animal; Dopamine; Growth Hormone; Humans; Huntington Disease; Levodopa; Nervous System Diseases; Parkinson Disease | 1981 |
The use of clozapine in neurologic disorders.
Topics: Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Humans; Levodopa; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Tremor | 1994 |
Does levodopa accelerate Parkinson's disease?
Topics: Animals; Clinical Trials as Topic; Dopamine; Humans; Levodopa; Nervous System Diseases; Oxidative Stress; Parkinson Disease | 1999 |
Catecholamines and neurologic diseases (second of two parts).
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Brain Diseases; Catecholamines; Cerebrovascular Disorders; Dopamine; Dysautonomia, Familial; Dystonia Musculorum Deformans; Hepatic Encephalopathy; Homovanillic Acid; Humans; Huntington Disease; Levodopa; Movement Disorders; Multiple Sclerosis; Nervous System Diseases; Parkinson Disease; Phenylketonurias; Seizures; Spinal Cord Injuries; Torticollis; Tourette Syndrome | 1975 |
[Therapeutic use of L-dopa].
Topics: Endocrine System Diseases; Humans; Levodopa; Liver Diseases; Nervous System Diseases; Skin Diseases | 1975 |
Drug-induced neurological disorders.
Topics: Antihypertensive Agents; Aspirin; Brain Diseases; Dyskinesia, Drug-Induced; Humans; Levodopa; Nervous System Diseases; Neuromuscular Diseases | 1990 |
6 trial(s) available for levodopa and Nervous System Disorders
Article | Year |
---|---|
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
Levodopa failure in chronic manganism.
Topics: Adult; Chronic Disease; Double-Blind Method; Humans; Levodopa; Male; Manganese Poisoning; Middle Aged; Movement Disorders; Nervous System Diseases; Placebos | 1994 |
The clinicopathologic spectrum of Lewy body disease.
Topics: Adolescent; Aged; Antiparkinson Agents; Brain; Dementia; Family; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Nervous System Diseases; Parkinson Disease | 1996 |
Visual evoked potentials and spatiotemporal contrast sensitivity changes in idiopathic Parkinson's disease and multiple system atrophy.
Topics: Aged; Antiparkinson Agents; Atrophy; Contrast Sensitivity; Evoked Potentials, Visual; Female; Humans; Levodopa; Male; Middle Aged; Motion Perception; Movement; Nervous System Diseases; Parkinson Disease; Space Perception; Time Perception; Vision, Monocular | 1996 |
The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism.
Topics: Aged; Antiparkinson Agents; Atrophy; Autonomic Nervous System; Brain; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Nervous System Diseases; Parkinson Disease; Prospective Studies; Retrospective Studies | 1996 |
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly.
Topics: Administration, Oral; Aged; Analysis of Variance; Antiparkinson Agents; Benzophenones; Catechol O-Methyltransferase Inhibitors; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Erythrocytes; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Nitrophenols; Tolcapone | 1997 |
32 other study(ies) available for levodopa and Nervous System Disorders
Article | Year |
---|---|
Neuroinflammation: Fanning the fire of l-dopa-induced dyskinesia.
Topics: Animals; Antiparkinson Agents; Cytokines; Disease Models, Animal; Dyskinesia, Drug-Induced; Humans; Inflammation; Levodopa; Nervous System Diseases; Tumor Necrosis Factor-alpha | 2019 |
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders.
Topics: Animals; Antipsychotic Agents; Blinking; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Isoquinolines; Levodopa; Macaca mulatta; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nervous System Diseases; Prefrontal Cortex; Psychotic Disorders; Receptors, Dopamine D1; Reserpine; Sleep; Wakefulness | 2018 |
Levodopa, vitamins, ageing and the neuropathy of Parkinson's disease.
Topics: Adult; Aged; Aging; Antiparkinson Agents; Cross-Sectional Studies; Female; Folic Acid; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Vitamin B 12 | 2013 |
[General anaesthesia for neurological diseases].
Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Autonomic Nervous System; Brain; Bromocriptine; Dopamine Agonists; Humans; Intubation; Levodopa; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Nervous System Diseases; Neurodegenerative Diseases; Neurosurgery; Parkinson Disease; Piperidines; Premedication; Preoperative Care; Propofol; Remifentanil; Selegiline; Stereotaxic Techniques; Syndrome | 2010 |
Pyridoxal 5'-phosphate in cerebrospinal fluid; factors affecting concentration.
Topics: Adolescent; Adult; Biopterins; Child; Child, Preschool; Cysteine; Epilepsy; False Positive Reactions; Female; Free Radicals; Humans; Infant; Infant, Newborn; Levodopa; Male; Metabolism, Inborn Errors; Middle Aged; Nervous System Diseases; Oxygen; Pyridoxal Phosphate; Reference Values; Reproducibility of Results; Sulfites; Tetrahydrofolates | 2011 |
The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.
Topics: Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Functional Laterality; Levodopa; Male; Medial Forebrain Bundle; Nervous System Diseases; Oxidopamine; Parkinson Disease, Secondary; Psychomotor Performance; Rats; Rats, Wistar; Sympatholytics; Walking | 2012 |
Child neurology: paroxysmal stiffening, upward gaze, and hypotonia: hallmarks of sepiapterin reductase deficiency.
Topics: 5-Hydroxytryptophan; Alcohol Oxidoreductases; Behavior; Benserazide; Consanguinity; Developmental Disabilities; Dopamine Agents; Drug Combinations; Eye Movements; Female; Humans; Infant; Levodopa; Movement Disorders; Muscle Hypotonia; Nervous System Diseases; Neurotransmitter Agents; Phenylketonurias; Treatment Outcome | 2012 |
The spectrum of nonmotor symptoms in early Parkinson disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition; Cohort Studies; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Parkinson Disease; Surveys and Questionnaires | 2013 |
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Interactions; Levodopa; Maze Learning; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nervous System Diseases; Nitrophenols; Oxazoles; Oxidopamine; Prefrontal Cortex; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin; Stereotyped Behavior; Tolcapone; Tremor; Tyramine | 2004 |
[Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
Topics: Adult; Aged; Carbidopa; Catecholamines; Drug Combinations; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Muscular Dystrophies; Nervous System Diseases; Neurotic Disorders; Parkinson Disease | 1983 |
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
Topics: Brain Chemistry; Cerebellar Diseases; Creatine Kinase; Dementia; Diet; Encephalitis; Epilepsy; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hypoxia; Levodopa; Multiple Sclerosis; Muscular Dystrophies; Nervous System Diseases; Parkinson Disease; Tissue Preservation | 1980 |
Acquired Tourettism in adult life.
Topics: Adult; Encephalitis; Humans; Levodopa; Middle Aged; Nervous System Diseases; Tourette Syndrome | 1982 |
[Current problems in the diagnosis and treatment of hereditary diseases of the nervous system].
Topics: Basal Ganglia Diseases; Catecholamines; Dystonia Musculorum Deformans; Female; Genetic Carrier Screening; Hepatolenticular Degeneration; Humans; Levodopa; Nervous System Diseases; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis | 1982 |
gamma delta+ T cells are increased in patients with Parkinson's disease.
Topics: Aged; Blood Cells; Cerebrospinal Fluid; Female; Headache; Humans; Levodopa; Male; Middle Aged; Muscle Contraction; Nervous System Diseases; Parkinson Disease; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes | 1994 |
Progression after chronic manganese exposure.
Topics: Adult; Chronic Disease; Follow-Up Studies; Humans; Levodopa; Male; Manganese; Middle Aged; Movement Disorders; Nervous System Diseases; Occupational Exposure; Parkinson Disease, Secondary | 1993 |
A clinicopathologic study of 100 cases of Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease; Survival Analysis | 1993 |
[Parkinson "plus"].
Topics: Antiparkinson Agents; Humans; Levodopa; Nervous System Diseases; Parkinson Disease; Sensitivity and Specificity | 1997 |
How to achieve maximum benefit for the patient with Parkinson's disease.
Topics: Aged; Amantadine; Carbidopa; Diagnosis, Differential; Histamine H1 Antagonists; Humans; Levodopa; Nervous System Diseases; Occupational Therapy; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Psychotherapy; Trihexyphenidyl | 1976 |
Reversible spastic and pyramidal tract signs in a patient with Parkinson's disease on L-dopa.
Topics: Female; Humans; Levodopa; Middle Aged; Muscle Spasticity; Nervous System Diseases; Parkinson Disease, Secondary; Pyramidal Tracts | 1977 |
Chronic autonomic failure with postural hypotension.
Topics: Autonomic Nervous System; Blood Pressure; Bromocriptine; Cardiovascular System; Chronic Disease; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Nerve Degeneration; Nervous System Diseases; Pressoreceptors | 1979 |
[The activity of aminotransferases in serum and cerebrospinal fluid in neurological diseases (author's transl)].
Topics: Alanine Transaminase; Amyotrophic Lateral Sclerosis; Aspartate Aminotransferases; Craniocerebral Trauma; Friedreich Ataxia; Guanidines; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Nervous System Diseases; Parkinson Disease; Penicillins; Phenylketonurias; Transaminases | 1975 |
[New trends in clinical neurology].
Topics: Brain; Brain Diseases; Cerebral Cortex; Epilepsy; Evoked Potentials; Humans; Levodopa; Motor Neurons; Movement Disorders; Nervous System Diseases; Neurons; Pain; Radiculopathy; Spinal Nerves; Synaptic Transmission | 1976 |
Dihydropteridine reductase deficiency associated with severe neurologic disease and mild hyperphenylalaninemia.
Topics: 5-Hydroxytryptophan; Ascorbic Acid; Consanguinity; Dopamine; Humans; Infant; Levodopa; Liver; Male; NADH, NADPH Oxidoreductases; Nervous System Diseases; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Serotonin | 1979 |
[Key problems of clinical neurogenetics].
Topics: Diagnosis, Differential; Drug Evaluation; Genetic Diseases, Inborn; Humans; Levodopa; Nervous System Diseases; Penicillamine; Stereotaxic Techniques; USSR | 1976 |
[Treatment of uremic sympathicopathy with levodopa].
Topics: Adult; Autonomic Nervous System; Humans; Hypotension; Levodopa; Male; Nervous System Diseases; Posture; Uremia | 1977 |
Shy-Drager syndrome. Neuropathological correlation and response to levodopa therapy.
Topics: Brain; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nervous System Diseases; Spinal Cord; Syndrome | 1976 |
Motor impairments after methamphetamine-induced neurotoxicity in the rat.
Topics: Animals; Avoidance Learning; Disease Models, Animal; Dopamine; Fenfluramine; Levodopa; Male; Methamphetamine; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Serotonin | 1992 |
Case report: autonomic postganglionic denervation--sural nerve and saphenous vein biopsy.
Topics: Adult; Catecholamines; Denervation; Dopamine; Hormones; Humans; Levodopa; Microscopy, Electron; Nerve Degeneration; Nervous System Diseases; Saphenous Vein; Sural Nerve | 1992 |
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
[Pathogenesis and correction of disorders of the sympathetic-adrenal and immune systems in abortion].
Topics: Abortion, Threatened; Adrenal Gland Diseases; Adult; Antibody Formation; Female; Humans; Immune System Diseases; Immunity, Cellular; Levodopa; Nervous System Diseases; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Sympathetic Nervous System | 1985 |
Controlled-release levodopa/carbidopa. I. Sinemet CR3 treatment of response fluctuations in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Parkinson Disease | 1987 |
Malignant phenylketonuria due to defective synthesis of dihydrobiopterin.
Topics: 5-Hydroxytryptophan; Biopterins; Carbidopa; Drug Combinations; Female; Humans; Infant, Newborn; Levodopa; Male; Nervous System Diseases; Phenylalanine; Phenylketonurias; Pteridines; Tyrosine | 1985 |